Advertisement
Singapore markets closed
  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • Dow

    38,239.98
    +253.58 (+0.67%)
     
  • Nasdaq

    15,451.31
    +169.30 (+1.11%)
     
  • Bitcoin USD

    66,121.53
    +61.45 (+0.09%)
     
  • CMC Crypto 200

    1,422.90
    +8.14 (+0.58%)
     
  • FTSE 100

    8,036.57
    +12.70 (+0.16%)
     
  • Gold

    2,323.90
    -22.50 (-0.96%)
     
  • Crude Oil

    81.17
    -0.73 (-0.89%)
     
  • 10-Yr Bond

    4.6440
    +0.0210 (+0.45%)
     
  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     
  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     
  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Wall Street Is Bullish on Nektar Stock despite Stock Price Slump

Wall Street Is Bullish on Nektar Stock despite Stock Price Slump

Does Nektar's Stock Price Correction Signal a Good Opportunity? Nektar Therapeutics (NKTR) is a development-stage biotechnology company that has a drug pipeline focused on the treatment of cancer, autoimmune diseases, and chronic pain. The company has entered a number of key collaborations recently to advance its drug pipeline.